396 related articles for article (PubMed ID: 21784671)
1. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.
Srivastava P; Kapoor R; Mittal RD
Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671
[TBL] [Abstract][Full Text] [Related]
2. Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India.
Srivastava P; Lone TA; Kapoor R; Mittal RD
Arch Med Res; 2012 Feb; 43(2):117-24. PubMed ID: 22374248
[TBL] [Abstract][Full Text] [Related]
3. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
[TBL] [Abstract][Full Text] [Related]
5. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer].
Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692
[TBL] [Abstract][Full Text] [Related]
6. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
8. Association of MMP2 and MMP9 gene polymorphisms with the recurrent spontaneous abortion: A meta-analysis.
Yan Y; Fang L; Li Y; Yu Y; Li Y; Cheng JC; Sun YP
Gene; 2021 Jan; 767():145173. PubMed ID: 33007375
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.
Gautam KA; Muktanand T; Sankhwar SN; Goel A; Sankhwar PL; Rajender S
Cytokine; 2016 Jan; 77():152-6. PubMed ID: 26605964
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
[TBL] [Abstract][Full Text] [Related]
12. The protective role of the -1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection.
Singh N; Hussain S; Sharma U; Suri V; Nijhawan R; Bharadwaj M; Sobti RC
Tumour Biol; 2016 Apr; 37(4):5295-303. PubMed ID: 26561467
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants of matrix metalloproteinase (MMP2) gene influence metabolic syndrome susceptibility.
Yadav SS; Mandal RK; Singh MK; Usman K; Khattri S
Genet Test Mol Biomarkers; 2014 Feb; 18(2):88-92. PubMed ID: 24192303
[TBL] [Abstract][Full Text] [Related]
14. Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort.
Jaiswal PK; Goel A; Mandhani A; Mittal RD
Mol Biol Rep; 2012 May; 39(5):5615-21. PubMed ID: 22193624
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.
Wieczorek E; Reszka E; Jablonowski Z; Jablonska E; Krol MB; Grzegorczyk A; Gromadzinska J; Sosnowski M; Wasowicz W
BJU Int; 2013 Dec; 112(8):1207-14. PubMed ID: 23819551
[TBL] [Abstract][Full Text] [Related]
16. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
[TBL] [Abstract][Full Text] [Related]
17. The Association of Matrix Metalloproteinase-8 Promoter Genotypes in Breast Cancer.
Hsiao CL; Liu LC; Shih TC; Chuang CL; Chen GL; Wang HC; Pan SY; Shen TC; Tsai CW; Chang WS; Way TD; Chung JG; Bau DT
Anticancer Res; 2018 Apr; 38(4):2181-2185. PubMed ID: 29599337
[TBL] [Abstract][Full Text] [Related]
18. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer.
Yu C; Pan K; Xing D; Liang G; Tan W; Zhang L; Lin D
Cancer Res; 2002 Nov; 62(22):6430-3. PubMed ID: 12438229
[TBL] [Abstract][Full Text] [Related]
19. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
O-Charoenrat P; Khantapura P
Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
[TBL] [Abstract][Full Text] [Related]
20. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
